Literature DB >> 22083242

Therapy: two birds, one stone: tadalafil is an effective treatment for men with both BPH-LUTS and ED.

Nick Warde.   

Abstract

Entities:  

Year:  2011        PMID： 22083242     DOI： 10.1038/nrurol.2011.165

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  3 in total

1.  Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats.

Authors:  Annamaria Morelli; Erica Sarchielli; Paolo Comeglio; Sandra Filippi; Rosa Mancina; Mauro Gacci; Linda Vignozzi; Marco Carini; Gabriella B Vannelli; Mario Maggi
Journal:  J Sex Med       Date:  2011-08-03       Impact factor: 3.802

2.  Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.

Authors:  Russell Blair Egerdie; Stephen Auerbach; Claus G Roehrborn; Pierre Costa; Martin Sanchez Garza; Anne L Esler; David G Wong; Roberta J Secrest
Journal:  J Sex Med       Date:  2011-10-07       Impact factor: 3.802

3.  Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.

Authors:  Hartmut Porst; Edward D Kim; Adolfo R Casabé; Vincenzo Mirone; Roberta J Secrest; Lei Xu; David P Sundin; Lars Viktrup
Journal:  Eur Urol       Date:  2011-08-12       Impact factor: 20.096
  3 in total
  1 in total

Review 1.  BPH in 2012: novel agents in treatment of BPH.

Authors:  Bilal Chughtai; Alexis Te
Journal:  Nat Rev Urol       Date:  2013-01-08       Impact factor: 14.432
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.